exhibited, κ = 0.470. There were signifi cant diff erences between the levels of agreement amongst the ratings of the radiologists, advanced practitioners and others (all P <0.05). Conclusions The low agreement rates between participants for density ratings were surprising. That there were diff erences between the occupational groupings may refl ect breast screening experience.
Introduction
The prevalent round recall rate is higher than the incident recall rate. Implementation of age extension will lead to two prevalent rounds and with this increased clinical and fi nancial pressure on screening units. Any processes that help reduce the recall rate will be of benefi t to screening units. Methods Retrospective data were collected from April 2008 to March 2009 of prevalent round ladies recalled to assessment clinics. The data recorded included reason for recall, imaging fi ndings and needle test results. Results A total of 7,627 women were invited for screening in April 2008 to March 2009, of which 5,341 attended. Four hundred and eighty-one ladies were recalled to assessment; 451/481 of the packets available were reviewed. Forty cancers were identifi ed in 39 patients. All cases of malignancy were coded as RU, RS or RM at the time of fi lm reading. Thirty-two patients were recalled for both sides, four patients recalled for two lesions within the same breast. Nineteen patients were clinical recalls (BA). All solitary RB masses thought to be benign at the time of fi lm reading proved to be benign (91/215 masses). Ten cases recalled for bilateral RB masses were benign. Thirty-six out of 140 asymmetries thought to be benign at the time of fi lm reading were benign. Conclusions The recall rate may be reduced in the prevalent round by not recalling solitary RB masses, bilateral RB masses, and asymmetry that appears physiological/benign on two views. In this unit this would have reduced the recall rate without adversely aff ecting the cancer detection rate. Introduction Imaging alone cannot reliably distinguish benign/malignant breast disease or assess the extent of cancer. This study assesses the feasibility of using additional information obtained at US (BHS) to aid diagnosis and preoperative assessment. Methods 3D US scans at 8 MHz, 12 MHz, 15 MHz were obtained of breast tissue in normal volunteers in two planes and with/without harmonics. Five volumes of sagittal scans at 8 MHz from three individuals were used to identify normal characteristics and defi ne the baseline. The 3D volume was divided into voxels (0.1 x 2 x 1.5 mm) and raw data from each voxel were analysed by applying linear and nonlinear classifi ers to assess 29 statistical characteristics (BHS). The training dataset contained 300,000 voxels. After training, the classifi er's output showed 3% error on both normal and abnormal tissue. The algorithm was tested on 32 further volumes representing 6,000,000 voxels of normal and abnormal tissue from 20 individuals. Abnormal tissue included various biopsy-proven lesions: malignancy (six), papilloma (one), hamartoma (one), fi broadenoma (two), cyst (two), fi brosis (one). Subclassifi ers were developed to distinguish between cancer and benign voxels. Results In 17 normal testing volumes, 3% of isolated voxels were classifi ed as abnormal. In 15 abnormal testing volumes, the subclassifi ers diff erentiated between malignant and benign tissue. BHS in benign tissue showed <1% abnormal voxels in cyst, hamartoma, papilloma and benign fi brosis. The fi broadenomas diff ered showing <5% and <24% abnormal voxels. Abnormal voxels in cancers increased with the volume of cancer at pathology. Conclusions Histoscanning reliably discriminated normal from abnormal tissue and could distinguish between benign and malignant lesions.
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